Paragonix SherpaPak™ Cardiac Transport System provides its pioneering technology for transplant surgeons at first West Coast location CAMBRIDGE, MASSACHUSETTS, September 28, 2020- Paragonix Technologies announced that its Paragonix SherpaPak™ Cardiac…

CAMBRIDGE, MASSACHUSETTS, July 20, 2020- Paragonix Technologies, Inc. today announced that its flagship product, Paragonix SherpaPak™ Cardiac Transport System (CTS), is the recipient of a prestigious international design award: the…

New data on successful transplantations for high-risk profile donor hearts presented at the American Transplant Congress CAMBRIDGE, MASSACHUSETTS, July 6, 2020- Paragonix Technologies, Inc. announced the presentation of new clinical…

Paragonix expands board to support rapid commercial growth in the heart transplant market CAMBRIDGE, MASSACHUSETTS, June 22, 2020- Paragonix Technologies, Inc. a commercial stage company and leader in organ preservation…

The Paragonix GUARDIAN Registry has reached its 100th patient enrollment milestoneCAMBRIDGE, MASSACHUSETTS, June 2, 2020- Paragonix Technologies, Inc. today announced that its clinical global registry, the Global Utilization And Registry…